Vascular Perfusion Solutions
Vascular Perfusion Solutions is dedicated to advancing organ preservation technology to save more lives through innovative, portable, and cost-effective perfusion systems. Their mission is to make more organs transplantable by overcoming current barriers related to organ viability during transport, utilizing purpose-built systems like the VP.S ENCORE® that extend donor organ viability and improve transplant outcomes.
Industries
Nr. of Employees
small (1-50)
Vascular Perfusion Solutions
1234 Medical Drive, San Antonio, TX 78229
Patents
Products
Portable hypothermic oxygenated perfusion system for cardiac preservation
A compact, battery-powered hypothermic oxygenated perfusion device intended to extend ex vivo cardiac graft viability using a blood-free perfusate and passive cooling, with an automatic fallback to cold static storage in case of perfusion interruption.
Portable hypothermic oxygenated perfusion system for cardiac preservation
A compact, battery-powered hypothermic oxygenated perfusion device intended to extend ex vivo cardiac graft viability using a blood-free perfusate and passive cooling, with an automatic fallback to cold static storage in case of perfusion interruption.
Services
Collaborative preclinical study design and execution using ex vivo and in vivo models, collection and analysis of functional and molecular endpoints, and co-development partnerships with clinical and academic centers.
Collaborative preclinical study design and execution using ex vivo and in vivo models, collection and analysis of functional and molecular endpoints, and co-development partnerships with clinical and academic centers.
Expertise Areas
- Organ preservation and machine perfusion
- Hypothermic oxygenated perfusion protocols
- Preclinical translational modeling (porcine and ex vivo human hearts)
- Perfusion monitoring and biomarker analysis
Key Technologies
- Hypothermic machine perfusion (HMP)
- Crystalloid (blood-free) perfusate formulations
- Ex vivo Langendorff heart perfusion model
- Orthotopic porcine heart transplant model
News & Updates
Former Mayor of San Antonio and 10th Secretary of Housing and Urban Development visits VPS headquarters in Jan 2025.
Rafael Veraza was featured as a speaker at MedTech Malta 2024 in Nov 2024.
Kristina Andrijauskaite participated as a grant awardee at the Midwest Pediatric Device Consortium Showcase in Oct 2024.
An article discussing advancements in pediatric heart transplantation using hypothermic oxygenated perfusion.
Research on extending preservation times for pediatric hearts with VP.S ENCORE®.
Study demonstrating the effectiveness of the VP.S ENCORE® device in preserving human hearts.
Former Mayor of San Antonio and 10th Secretary of Housing and Urban Development visits VPS headquarters in Jan 2025.
Rafael Veraza was featured as a speaker at MedTech Malta 2024 in Nov 2024.
Kristina Andrijauskaite participated as a grant awardee at the Midwest Pediatric Device Consortium Showcase in Oct 2024.
An article discussing advancements in pediatric heart transplantation using hypothermic oxygenated perfusion.
Research on extending preservation times for pediatric hearts with VP.S ENCORE®.
Study demonstrating the effectiveness of the VP.S ENCORE® device in preserving human hearts.